Detalles de la búsqueda
1.
Characteristics of pleural effusion due to paradoxical response in patients with pulmonary tuberculosis.
J Infect Chemother
; 29(9): 890-894, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244351
2.
Usefulness of gastric aspirate for the diagnosis of smear-negative pulmonary tuberculosis.
J Infect Chemother
; 28(7): 1041-1044, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35450783
3.
Multidrug Resistant Tuberculosis With Simultaneously Acquired Drug Resistance to Bedaquiline and Delamanid.
Clin Infect Dis
; 73(12): 2329-2331, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32730621
4.
Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patients.
J Infect Chemother
; 27(2): 237-242, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060045
5.
Serum Procalcitonin Levels Predict Mortality Risk in Patients With Pulmonary Tuberculosis: A Single-Center Prospective Observational Study.
J Infect Dis
; 222(10): 1651-1654, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445568
6.
Limited benefit of CT scans in tuberculosis contact tracing.
J Infect Chemother
; 25(10): 764-768, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101527
7.
[THE FREQUENCIES AND MANAGEMENT OF ADVERSE REACTIONS IN MULTI-DRUG RESISTANT TUBERCULOSIS TREATMENT].
Kekkaku
; 92(1): 11-19, 2017 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-30646468
8.
Immunological Roles of Elevated Plasma Levels of Matricellular Proteins in Japanese Patients with Pulmonary Tuberculosis.
Int J Mol Sci
; 18(1)2016 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28025511
9.
[EXPERIENCE OF USE OF NEW ANTI-TUBERCULOUS DRUG, DELAMANID IN MULTI- AND EXTENSIVELY DRUG RESISTANT TUBERCULOSIS CASES IN OUR HOSPITAL].
Kekkaku
; 91(11-12): 699-702, 2016 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-30648372
10.
[CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011].
Kekkaku
; 90(10): 665-70, 2015 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-26821395
11.
[Experience of rapid drug desensitization therapy in the treatment of mycobacterial disease].
Kekkaku
; 89(11): 797-802, 2014 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-25730947
12.
Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB.
Chest
; 165(2): 267-277, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37726072
13.
[Estimating the prevalence of tuberculosis infection among healthcare workers in our hospital by repeat QFT-G testing].
Kekkaku
; 88(4): 405-9, 2013 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-23819316
14.
[Clinical factors of pulmonary tuberculosis in non-tuberculosis wards and its incidence among contact patients and healthcare workers in our hospital using QuantiFERON GOLD testing].
Kekkaku
; 88(7): 605-9, 2013 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-23986942
15.
[Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients].
Kekkaku
; 88(8): 625-8, 2013 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-24044166
16.
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017-2022.
Respir Med Case Rep
; 45: 101902, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37538979
17.
Relationship between the thickness of erector spinae muscles and mortality in patients with pulmonary tuberculosis.
Respir Investig
; 61(4): 511-519, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37267852
18.
[Can an individual with a positive baseline QuantiFERON test result develop active tuberculosis?].
Kekkaku
; 87(11): 697-9, 2012 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-23367827
19.
Analysis of risk factors for pulmonary tuberculosis with persistent severe inflammation: An observational study.
Medicine (Baltimore)
; 101(19): e29297, 2022 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583541
20.
[Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital].
Kekkaku
; 86(11): 863-8, 2011 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-22250465